We are live on ! Find out more
VFA

Valeo Financial Advisors Portfolio holdings

AUM $4.74B
1-Year Est. Return 27.69%
This Fund
S&P 500
This Quarter Est. Return
+0.4%
1 Year Est. Return
+27.69%
3 Year Est. Return
+75.87%
5 Year Est. Return
+85.74%
10 Year Est. Return
AUM
$3.59B
AUM Growth
+$85.8M
Cap. Flow
+$167M
Cap. Flow %
4.65%
Top 10 Hldgs %
49.66%
Holding
798
New
95
Increased
301
Reduced
284
Closed
57

Top Buys

Rank Stock Value
1
JCPB icon
JPMorgan Core Plus Bond ETF
JCPB
+$52.7M
2
LLY icon
Eli Lilly
LLY
+$39.7M
3
FBND icon
Fidelity Total Bond ETF
FBND
+$32.9M
4
AAPL icon
Apple
AAPL
+$19.9M
5
MSFT icon
Microsoft
MSFT
+$19.2M

Sector Composition

Rank Sector Weight
1 Technology 11.94%
2 Financials 6.14%
3 Healthcare 5.18%
4 Consumer Discretionary 3.86%
5 Communication Services 3.32%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LCID icon
726
Lucid Motors
LCID
$2.61B
$32.3K ﹤0.01%
1,071
-85
-7% -$2.21K
RIG icon
727
Transocean
RIG
$5.69B
$30.7K ﹤0.01%
16,626
-3,474
-17% -$14.4K
DISCK
728
DELISTED
Discovery, Inc. Series C Common Stock
DISCK
$27.5K ﹤0.01%
27,480
THCX
729
DELISTED
AXS Cannabis ETF
THCX
$24.9K ﹤0.01%
24,900
TLRY icon
730
Tilray
TLRY
$602M
$24.6K ﹤0.01%
1,874
-135
-7% -$1.98K
XBI icon
731
CALL
State Street SPDR S&P Biotech ETF
XBI
$9.99B
$22K ﹤0.01%
+3,400
New +$329K
XBI icon
732
PUT
State Street SPDR S&P Biotech ETF
XBI
$9.99B
$22K ﹤0.01%
+3,400
New +$329K
GEVO icon
733
Gevo
GEVO
$372M
$20.9K ﹤0.01%
10,000
HRTX icon
734
Heron Therapeutics
HRTX
$95.5M
$20.7K ﹤0.01%
13,533
+615
+5% +$997
SOFI icon
735
PUT
SoFi Technologies
SOFI
$23.5B
$16.9K ﹤0.01%
+1,100
New +$14.3K
RDFN
736
CALL
DELISTED
Redfin
RDFN
$15.7K ﹤0.01%
+2,000
New +$19.4K
MVIS icon
737
CALL
Microvision
MVIS
$74M
$13.1K ﹤0.01%
667
-333
-33% -$5.25K
NIO icon
738
CALL
NIO
NIO
$11.7B
$13.1K ﹤0.01%
+3,000
New +$15.3K
SLE icon
739
Super League Enterprise
SLE
$4.2M
$12.3K ﹤0.01%
+42
New +$15.7K
X
740
CALL
DELISTED
US Steel
X
$599 ﹤0.01%
+400
New +$14.8K
X
741
PUT
DELISTED
US Steel
X
$599 ﹤0.01%
+400
New +$14.8K
AWK icon
742
American Water Works
AWK
$26.7B
-1,855
Closed -$271K
BANC icon
743
Banc of California
BANC
$3.07B
-16,422
Closed -$242K
BAX icon
744
Baxter International
BAX
$14.1B
-5,737
Closed -$218K
BIIB icon
745
Biogen
BIIB
$30.5B
-1,563
Closed -$303K
BIV icon
746
Vanguard Intermediate-Term Bond ETF
BIV
$28.9B
-3,244
Closed -$254K
BNDX icon
747
Vanguard Total International Bond ETF
BNDX
$82.3B
-5,218
Closed -$262K
BUD icon
748
AB InBev
BUD
$168B
-3,039
Closed -$201K
BWA icon
749
BorgWarner
BWA
$13.7B
-7,419
Closed -$270K
CAT icon
750
CALL
Caterpillar
CAT
$401B
-1,400
Closed -$548K

Similar funds

Valeo Financial Advisors's Q4 2024 Portfolio in Review

As of Q4 2024, Valeo Financial Advisors held 798 positions worth $3.59B, up 2.4% from $3.51B the previous quarter. Its ten largest holdings account for 50% of the portfolio.

Valeo Financial Advisors deployed $167M of net new capital in Q4 2024, opening 95 new positions and adding to 301 existing holdings. Its largest new stake was Lam Research: 18,181 shares worth $1.31M.

By sector, the portfolio is most concentrated in Technology at 12% of assets, up from 12% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Vanguard Short-Term Corporate Bond ETF, an estimated $13.8M trimmed.

  • Valeo Financial Advisors's largest Q4 2024 buy was Lam Research: 18,181 shares worth $1.31M.
  • Valeo Financial Advisors added most to JPMorgan Core Plus Bond ETF in Q4 2024, an estimated $52.7M increase.
  • Valeo Financial Advisors's biggest Q4 2024 reduction was Vanguard Short-Term Corporate Bond ETF, cutting an estimated $13.8M.
  • Valeo Financial Advisors fully exited Western Alliance Bancorporation in Q4 2024, selling an estimated $623K.
  • Valeo Financial Advisors's ten largest holdings make up 50% of its $3.59B portfolio in Q4 2024.
  • Valeo Financial Advisors opened 95 new positions and closed 57 in Q4 2024.
  • Valeo Financial Advisors's portfolio value rose 2.4% quarter-over-quarter to $3.59B.

Based on Valeo Financial Advisors's 13F filing for Q4 2024, filed 30 Jan 2025.